Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 866 of 866 entries
View as:

A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor

Phase: N/A Priority: Normal
NCT ID: NCT02365662 Org: User:
Start: 01/09/15 End: 03/15/18 Due: 03/15/19

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Phase: N/A Priority: Normal
NCT ID: NCT05141006 Org: User:
Start: 03/29/22 End: 12/06/24 Due: 12/06/25

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02499783 Org: User:
Start: 08/17/15 End: 12/15/17 Due: 12/15/18

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06345339 Org: User:
Start: 04/26/24 End: 06/30/28 Due: 06/30/29

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02640547 Org: User:
Start: 11/26/15 End: 03/29/17 Due: 03/29/18

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01594229 Org: User:
Start: 05/21/12 End: 07/14/20 Due: 07/14/21

A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06722417 Org: User:
Start: 11/26/24 End: 01/17/25 Due: 01/17/26

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine

Phase: N/A Priority: Normal
NCT ID: NCT05935033 Org: User:
Start: 06/30/23 End: 02/21/25 Due: 02/21/26

A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT05394805 Org: User:
Start: 06/29/22 End: 12/26/24 Due: 12/26/25

A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06722430 Org: User:
Start: 11/13/24 End: 01/13/25 Due: 01/13/26

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03478787 Org: User:
Start: 05/08/18 End: 07/08/20 Due: 07/08/21

Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT03099083 Org: User:
Start: 03/31/17 End: 04/05/19 Due: 04/05/20

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03737851 Org: User:
Start: 12/11/18 End: 09/09/21 Due: 09/09/22

A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01958827 Org: User:
Start: 09/30/13 End: 10/31/15 Due: 10/31/16

Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06464692 Org: User:
Start: 09/30/24 End: 09/30/28 Due: 09/30/29

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

Phase: N/A Priority: Normal
NCT ID: NCT03671148 Org: User:
Start: 03/07/19 End: 06/12/26 Due: 06/12/27